Grand Total EEG Score Can Differentiate Parkinson's Disease From Parkinson-Related Disorders

Grand Total EEG Score Can Differentiate Parkinson's Disease From Parkinson-Related Disorders

Background: Semi-quantitative electroencephalogram (EEG) analysis is easy to perform and has been used to differentiate dementias, as well as idiopathic and vascular Parkinson's disease.Purpose: To study whether a semi-quantitative EEG analysis can aid in distinguishing idiopathic Parkinson...

Full description

Bibliographic Details
Main Authors:	Ela Austria Barcelon, Takahiko Mukaino, Jun Yokoyama, Taira Uehara, Katsuya Ogata, Jun-ichi Kira, Shozo Tobimatsu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-04-01
Series:	Frontiers in Neurology
Subjects:	idiopathic Parkinson's disease atypical Parkinsonian disorders corticobasal degeneration multiple system atrophy progressive supranuclear palsy grand total EEG score
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2019.00398/full

Similar Items

Challenges and Opportunities in Atypical Parkinsonian Syndromes: Call to Action
by: Roach M, et al.
Published: (2020-01-01)

Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes
by: Mehdi Maghbooli, et al.
Published: (2020-06-01)

Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders
by: Sonja W. Scholz, et al.
Published: (2015-10-01)

The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
by: Monica Diez-Fairen, et al.
Published: (2021-07-01)

Of Criteria and Men—Diagnosing Atypical Parkinsonism: Towards an Algorithmic Approach
by: Liviu Cozma, et al.
Published: (2021-05-01)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
by: Leonie Beyer, et al.
Published: (2018-06-01)

Clinical features of dystonia in atypical parkinsonism Características clínicas da distonia no parkinsonismo atípico
by: Clecio Godeiro-Junior, et al.
Published: (2008-12-01)

Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study
by: Rachel Rohmann, et al.
Published: (2021-06-01)

Clinical Approach to Progressive Supranuclear Palsy
by: Helen Ling
Published: (2016-01-01)

Brain Iron Accumulation in Atypical Parkinsonian Syndromes: in vivo MRI Evidences for Distinctive Patterns
by: Jae-Hyeok Lee, et al.
Published: (2019-02-01)

The role of diffusion magnetic resonance imaging in Parkinson's disease and in the differential diagnosis with atypical parkinsonism
by: Romulo Varella de Oliveira, et al.

Assessment of APOE in atypical parkinsonism syndromes
by: Marya S. Sabir, et al.
Published: (2019-07-01)

Gait improvement after levofloxacin administration in a progressive supranuclear palsy patient
by: Masanori Kurihara, et al.
Published: (2020-01-01)

Affective symptoms in progressive supranuclear palsy
by: K S Shaji, et al.
Published: (2014-01-01)

Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool
by: Katie A. Peterson, et al.
Published: (2021-07-01)

Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia
by: Shoichiro Ando, et al.
Published: (2020-01-01)

Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review
by: Mehri Salari, et al.
Published: (2016-01-01)

Discrimination of atypical parkinsonisms with transcranial magnetic stimulation
by: Alberto Benussi, et al.
Published: (2018-03-01)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
by: Maria Angela Samis Zella, et al.
Published: (2020-07-01)

Assisted Suicide in Parkinsonian Disorders
by: Georg S. Nuebling, et al.
Published: (2021-03-01)

Disease modification and Neuroprotection in neurodegenerative disorders
by: Jeffrey Cummings
Published: (2017-09-01)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
by: Brent Bluett, et al.
Published: (2021-07-01)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
by: Rebecca R. Valentino, et al.
Published: (2020-09-01)

Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders
by: Mang Ching Lai, et al.
Published: (2017-10-01)

Methods and utility of quantitative brainstem measurements in progressive supranuclear palsy versus Parkinson's disease in a routine clinical setting
by: Jessica Cooperrider, et al.
Published: (2020-01-01)

The diagnostic potential of multimodal neuroimaging measures in Parkinson's disease and atypical parkinsonism
by: Chang‐hyun Park, et al.
Published: (2020-11-01)

Divergent Thinking in Parkinsonism: A Case–Control Study
by: Margherita Canesi, et al.
Published: (2017-10-01)

The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy
by: Hai-Yan Zhou, et al.
Published: (2018-07-01)

Modeling the Triggering of Saccades, Microsaccades, and Saccadic Intrusions
by: Jorge Otero-Millan, et al.
Published: (2018-05-01)

Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide
by: Luisa Benussi, et al.
Published: (2009-03-01)

Exercise and Progressive Supranuclear Palsy: the need for explicit exercise reporting
by: Susan C. Slade, et al.
Published: (2019-11-01)

Whole-brain atrophy differences between progressive supranuclear palsy and idiopathic Parkinson's disease
by: Carlos Guevara, et al.
Published: (2016-09-01)

The Functional Role of microRNAs in the Pathogenesis of Tauopathy
by: Domenico Praticò
Published: (2020-10-01)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
by: Anna Vasilevskaya, et al.
Published: (2020-07-01)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
by: Gesine Respondek, et al.
Published: (2021-05-01)

The Diagnostic Scope of Sensor-Based Gait Analysis in Atypical Parkinsonism: Further Observations
by: Heiko Gaßner, et al.
Published: (2019-01-01)

Identification of circulating microRNAs for the differential diagnosis of Parkinson’s disease and Multiple System Atrophy.
by: Annamaria eVallelunga, et al.
Published: (2014-06-01)

Clinical Features and Disability Milestones in Multiple System Atrophy and Progressive Supranuclear Palsy
by: Sang-Wook Lee, et al.
Published: (2012-10-01)

The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
by: Lydia Chougar, et al.
Published: (2020-07-01)

How to spot ocular abnormalities in progressive supranuclear palsy? A practical review
by: Onanong Phokaewvarangkul, et al.
Published: (2019-07-01)